Breast cancer patients exhibit at least two types of Tregs, differentiated by their site of maturation: naturally occurring CD4+CD25+ Tregs (nTregs) in the thymus and inducible Tregs (iTregs) in peripheral tissues. This evidence concerns the gene CD4 and breast carcinoma.